Johnson & Johnson Stock Plunges 5% Despite Beating Q3 Earnings Estimates
JNJ stock dropped 5.39% despite reporting Q3 revenue of $25.4 billion, exceeding analyst forecasts.
JNJ stock dropped 5.39% despite reporting Q3 revenue of $25.4 billion, exceeding analyst forecasts. Hyperliquid (HYPE) is trading at $81.15, up 0.2% since this brief published. This is an original Token Times brief synthesising 2 outlets (Blockonomi, Crypto.news), with their figures cross-checked, plus live market data, as of Tue, 13 Oct 2026 18:30:01 UTC.
The stock's decline, despite strong earnings, suggests investor concerns about international market pressures and MedTech performance may outweigh positive results. This reaction highlights broader market sentiment and potential headwinds for healthcare giants.
- JNJ reported Q3 revenue of $25.4B, beating estimates of $25.28B.
- Stock fell 5.39% despite strong earnings and 68% growth in TREMFYA sales.
- MedTech revenue missed expectations due to international market challenges.
Blockonomi and Crypto.news both report that Johnson & Johnson (JNJ) stock dropped approximately 5% despite the company exceeding Q3 revenue expectations with $25.4 billion in earnings. They agree that the decline was driven by concerns over international market pressures and underperformance in the MedTech sector. However, Crypto.news emphasizes the stock's price drop to around $81.20, while Blockonomi focuses on the 5.39% decline.
Johnson & Johnson (JNJ) reported Q3 revenue of $25.4 billion, surpassing Wall Street's estimates of $25.28 billion, yet its stock price fell by 5.39%.
The decline comes despite strong performance in the pharmaceutical sector, with TREMFYA sales surging 68% to $2.4 billion. However, the company's MedTech revenue missed expectations, reflecting challenges in the international market.
Multiple outlets confirm the 5% drop in JNJ's stock price, with Crypto.news noting the price fell to around $81.20. This decline suggests that investor concerns about international market pressures and MedTech performance outweighed the positive earnings report.
In the broader market context, the total crypto market cap stands at $2.87 trillion, with 
Bitcoin up 0.93% in the last 24 hours. The Fear & Greed Index is at 57, indicating a state of 'Greed' among investors.
Meanwhile, 
Hyperliquid (HYPE), which has been in the news for its Assistance Fund's significant token purchases, has seen its price drop by 3.05% in the last 24 hours, currently trading at $81.01. This indicates a broader market trend of volatility despite positive news.
Since this brief published about 3 hours ago, Hyperliquid (HYPE) has moved from $81.01 to $81.15 — +0.17%.
The chart plots HYPE's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 HYPE ≈ ₹8,390.5 (about $81.15), down 2.7% over 24 hours. The rupee itself trades about 7.8% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
1 key figure independently matched across 2 outlets reporting this story.
Token Times extracts the figures each outlet reports and flags the ones that agree. Numbers cited by only one outlet are attributed in the brief, not shown as corroborated.
Figures and sectors in this story, checked live against on-chain aggregators · October 13, 2026.
Token Times reads these figures directly from on-chain aggregators (DeFiLlama, mempool.space) at build time — independent of what any outlet reported. Sector totals aggregate every protocol DeFiLlama tracks in that category. Values are live and will change.
Johnson & Johnson Stock Plunges 5% Despite Beating Q3 Ea — questions & answers
Why did JNJ stock drop despite strong Q3 earnings?
The decline is attributed to concerns over international market pressures and underperformance in the MedTech sector.
What was the impact of TREMFYA on JNJ's Q3 results?
TREMFYA sales surged 68% to $2.4 billion, contributing to strong pharmaceutical growth.
How did Hyperliquid's Assistance Fund affect HYPE's price?
Despite the Assistance Fund spending $1.36 billion on over 48 million tokens, HYPE's price fell by 3.05% in the last 24 hours.
How much is 1 Hyperliquid worth in rupee today?
About ₹8,390.5 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $81.15. The rupee price moves with both HYPE's US-dollar price and the USDT/INR rate; use our Hyperliquid in rupee page for any amount.
Has Hyperliquid's price moved since this brief was published?
HYPE is up 0.17% since this brief first published — trading at $81.15 now versus $81.01 at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from Blockonomi, Crypto.news, with the key figures cross-checked for agreement across them. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.